Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

4.3K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
4.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

10.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.2K
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

10.8K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
10.8K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

630
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
630
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.4K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogen-Bond Network Collapse and Molecular Confinement in Ethanol-Water Mixtures at the Azeotrope.

The journal of physical chemistry letters·2026
Same author

Cyclable manganese inventory as a mechanistic descriptor for electrolyte design in rechargeable aqueous Zn-MnO<sub>2</sub> batteries.

Chemical communications (Cambridge, England)·2026
Same author

Raman evidence for a solvation-heterogeneity-mediated precipitation pathway of sodium sulfate in water-DMSO mixtures.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Cavity-Enhanced Raman Spectroscopy Revealed Competitive Hydrogen-Bond Restructuring in Ethanol-Water Solutions.

The journal of physical chemistry letters·2026
Same author

Study on the above-threshold ionization of atoms driven by laser pulses with a small chirp.

Optics express·2026
Same author

Synergistic Interphase-Solvation Dual-Regulation Engineering via a Zwitterion Electrolyte Additive for Ultrastable Zn Metal Anodes.

ACS applied materials & interfaces·2026

Related Experiment Video

Updated: Mar 10, 2026

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

875

Role of albumin in regulating platelet function.

Qiwen Tai1, Mengnan Yang1, Shuang Chen2

  • 1Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, NHC Key Laboratory of Thrombosis and Hemostasis, National Clinical Research Center for Hematologic, Suzhou, China.

Frontiers in Pharmacology
|March 9, 2026
PubMed
Summary

Albumin inhibits platelet activation and thrombus formation by modulating signaling pathways and utilizing its negative surface charge. This finding offers new insights into managing thrombosis risks associated with hypoproteinemia.

Keywords:
albuminhypoproteinemiaplatelet activationsignal transduction pathwaythrombus

More Related Videos

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.5K

Related Experiment Videos

Last Updated: Mar 10, 2026

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

875
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.8K
A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

14.5K

Area of Science:

  • Biochemistry
  • Hematology
  • Molecular Biology

Background:

  • Hypoproteinemia can lead to serious complications like thrombosis.
  • Albumin is a therapeutic agent, but its role in thrombosis regulation is not fully understood.
  • Existing clinical data on albumin's effect on thrombosis is conflicting.

Purpose of the Study:

  • To investigate the mechanisms by which albumin affects platelet thrombus formation.
  • To clarify the regulatory effects of albumin on thrombosis.

Main Methods:

  • Platelet function experiments, including aggregation and activation assays.
  • Western blot analysis to examine signaling pathways (PKC, Akt).
  • Protein charge neutralization studies and animal models (murine hypoproteinemia model).

Main Results:

  • Albumin significantly inhibited platelet thrombus formation and aggregation in vivo and in vitro.
  • Albumin suppressed platelet granule release, altered granule distribution, and inhibited platelet spreading.
  • The negative surface charge of albumin was identified as critical for its inhibitory effects on platelet activation.

Conclusions:

  • Albumin inhibits platelet activation and thrombus formation.
  • This inhibition is mediated by albumin's negatively charged surface residues.
  • Modulation of Protein Kinase C (PKC) and Akt signaling pathways is involved in albumin's mechanism.